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Protective Effect of MFG-E8 after Cutaneous
Ischemia–Reperfusion Injury
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Osamu Ishikawa1 and Sei-ichiro Motegi1
We recently demonstrated that the secreted glycoprotein and integrin-ligand MFG-E8 promotes cutaneous
wound healing by enhancing angiogenesis. Several studies have identified potential roles for MFG-E8 in
regulation of ischemia–reperfusion (I/R) injury in the brain, kidney, and liver. Our objective was to assess the role
of MFG-E8 in the formation of skin ulcers using a murine model of cutaneous I/R injury–cutaneous pressure
ulcers. Cutaneous I/R was performed by trapping the dorsal skin between two magnetic plates for 12hours,
followed by plate removal. Expression of MFG-E8 increased in the dermis during ischemia, and then decreased
after reperfusion. Administration of recombinant (r)MFG-E8 in I/R areas at the beginning of reperfusion
significantly inhibited the formation of cutaneous pressure ulcers, and the number of CD31þ vessel and
NG2þ pericytes in wounds were increased in I/R mice treated with rMFG-E8. The number of M1 macrophages
and the amount of proinflammatory mediators monocyte chemotactic protein-1,induced nitric oxide synthase,
IL-6, tumor necrosis factor-a, and IL-1b in the wound area were reduced by the administration of rMFG-E8. We
conclude that MFG-E8 may inhibit the formation of pressure ulcers induced by cutaneous I/R injury by regulating
angiogenesis and inflammation. Exogenous application of MFG-E8 might have therapeutic potential for
cutaneous I/R injuries, including decubitus ulcers and Raynaud’s phenomenon–induced digital ulcers.
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INTRODUCTION
Pressure ulcers are increasing over the world owing to aging of
the population. Pressure ulcers are significant sources of pain
and distress, leading to the impairment of the quality of life of
patients (Gorecki et al., 2009). Although it has long been
considered that chronic tissue ischemia was a primary factor
in the pathogenesis of pressure ulcers, there has been
increasing evidence that ischemia–reperfusion (I/R) is asso-
ciated with the pathogenesis of pressure ulcers (Salcido et al.,
1994; Peirce et al., 2000; Stadler et al., 2004). Many studies of
I/R injury in various organs, including the brain, kidney, and
liver, suggested that the pathogenesis of I/R injury was quite
complex and different from that of the injury by chronic
ischemia (Carden and Granger, 2000). I/R injury is defined as
a cellular injury caused by the reperfusion of blood to
previously ischemic tissue, and the cascade of harmful
events, including dysfunction of endothelial cells, edema,
capillary narrowing, leukocyte and macrophage infiltration,
production of proinflammatory cytokines, and, thereafter, the
apoptosis and necrosis of tissues (Pretto 1991; Wolfson et al.,
1994). Therefore, I/R injury causes more severe tissue damage
compared with ischemia alone (Carden and Granger, 2000;
Carmo-Arau´jo et al., 2007). Reactive oxygen species also have
essential roles in tissue damage by reperfusion. Nitric oxide
(NO) is one of the reactive oxygen species, and excessive
NO or its synthase, inducible NO synthase (iNOS), is
associated with the pathogenesis of I/R-induced apoptosis
and tissue injury (Nathan and Xie, 1994; Reid et al., 2004;
Kasuya et al. 2014). Saito et al.,(2008) reported that cutaneous
I/R induced the recruitment of neutrophils and macrophages
and the subsequent release of proinflammatory cytokines,
including IL-1b, IL-6, and tumor necrosis factor-a
(TNF-a), and toxic oxygen-derived free radicals induced the
apoptosis of skin fibroblasts and skin injury. In addition,
they reported that monocyte chemoattractant protein-1
(MCP-1) was an important factor for macrophage
recruitment and it had a role in apoptosis and injury via
inducing iNOS during reperfusion rather than the ischemic
period (Saito et al., 2008).
The secreted glycoprotein MFG-E8, also called lactadherin
and SED1, is composed of two N-terminal EGF-like domains
and two C-terminal discoidin-like domains (C1 and C2) that
share homology with blood coagulation factors V and VIII
(Stubbs et al., 1990; Ogura et al., 1993). One EGF-like domain
(E2) contains RGD integrin-binding motif, and MFG-E8 binds
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to integrin avb3/5 (Andersen et al., 1997; Taylor et al., 1997;
Hanayama et al., 2002). MFG-E8 acts as a bridging protein
between phosphatidylserine on the surface of apoptotic cells
and integrin avb3/5 on the surface of phagocytes, and it
enhances the phagocytosis and clearance of apoptotic cells
(Hanayama et al., 2002; Asano et al., 2004).
With respect to the regulation of angiogensis, there are
several reports stating that the interactions of MFG-E8 with
integrin av have been implicated in the enhancement of
angiogenesis in mice (Silvestre et al., 2005; Neutzner et al.,
2007). Recently, we demonstrated that pericytes and/or
pericyte precursors were important sources of MFG-E8 in
melanoma tumors in mice, and that MFG-E8 enhanced
angiogenesis in melanoma tumors and in oxygen-induced
retinopathy in mice (Motegi et al., 2011a). We have also
determined that MFG-E8 associated with integrin av and
platelet-derived growth factor receptor b (PDGFRb) on the
surface of pericytes after platelet-derived growth factor (PDGF)
treatment, and inhibited PDGF-stimulated degradation of
PDGFRb, resulting in the enhancement of PDGFRb signaling
mediated by integrin–growth factor receptor cross talk (Motegi
et al., 2011b). Moreover, we recently demonstrated that MFG-
E8 is important for cutaneous wound healing using a mouse
model with full-thickness cutaneous wounds (Uchiyama et al.,
2014), in which MFG-E8 was increased in granulation tissue
in cutaneous wound area. Wound healing was significantly
delayed in MFG-E8 knockout (KO) mice compared with wild-
type (WT) mice, and recombinant mouse MFG-E8 (rMFG-E8)
treatment enhanced wound healing in MFG-E8 KO mice.
These results suggest that MFG-E8 could be effectively
targeted with therapeutic benefit for the wound caused by
ischemic disorders.
Recent studies revealed that MFG-E8 significantly reduces
inflammation and protects tissue injury after I/R in several
organs including the brain, liver, kidney, and gut (Matsuda
et al., 2011; Wu et al., 2012; Deroide et al., 2013; Matsuda
et al., 2013). These studies demonstrated that MFG-E8 mRNA
and protein expression in organs, including kidney, liver, and
gut, were significantly decreased by I/R, and that treatment
with rMFG-E8 recovered organ dysfunction and suppressed
inflammatory responses. From these previous findings and our
results, we hypothesized that treatment with rMFG-E8 might
prevent tissue damage and promote angiogenesis in cutaneous
I/R injury. However, the possible role of MFG-E8 in cutaneous
I/R injury has not been studied previously. Herein, we
analyzed changes of the expression of MFG-E8 in cutaneous
I/R injury, and the effect of the treatment with rMFG-E8 in
cutaneous I/R injury of mouse skin.
RESULTS
Expression of MFG-E8 during cutaneous I/R in vivo
To investigate the effect of cutaneous I/R injury on MFG-E8
expression in vivo, mRNA levels of MFG-E8 expression in the
skin of I/R sites during I/R injury were analyzed. Levels of
MFG-E8 mRNA increased in the skin during ischemia by 2.5-
fold compared with that before I/R, and then immediately
decreased to the basal levels at 4 hours after reperfusion,
followed by a gradual decrease by 0.5-fold at 72 hours after
reperfusion compared with that before I/R (Figure 1a). These
results suggest that MFG-E8 expression was enhanced by
hypoxic condition owing to the ischemia.
To assess which kinds of cells in skin can contribute to the
increased MFG-E8 expression during ischemia, we performed
immunofluorescence staining of MFG-E8 in skin before
ischemia (12 hours), just after reperfusion (0 hour), and
72 hours after reperfusion (72 hours). We determined that
MFG-E8 expression around CD31þ ECs and aSMAþ (a-
smooth muscle actin) pericytes/vascular smooth muscle cells
(SMCs) just after reperfusion (0 hour) was enhanced compared
with that before ischemia (12 hours) and 72 hours after
reperfusion (72 hours; Figure 1b). These results suggest that
ECs and pericytes/vascular SMCs might be primary sources of
MFG-E8 during ischemia.
Expression of MFG-E8 in pericyte-like cells, endothelial cells, and
fibroblasts treated with hypoxic condition in vitro
We previously determined that pericytes were the major
sources of MFG-E8 in B16 melanoma tumors, and that
MFG-E8 localized in close proximity to pericytes/vascular
SMCs in the dermis of murine and human skin (Motegi et al.,
2011a; Uchiyama et al., 2014). In addition, immuno-
fluorescence staining of skin in the I/R site showed that the
MFG-E8 expression levels around blood vessels were
enhanced during ischemia. Therefore, we next examined
whether hypoxic condition enhanced the expression of
MFG-E8 in pericytes, ECs, and fibroblasts in vitro. In 10T1/2
cells, which are surrogates for pericytes and pericyte
precursors, MFG-E8 mRNA levels were significantly
enhanced by hypoxia in a time-dependent manner
(Figure 1c). MFG-E8 mRNA levels in ECs (human umbilical
vein endothelial cells) were also significantly enhanced by
hypoxia in a time-dependent manner (Figure 1c). MFG-E8
mRNA levels in fibroblasts (NIH3T3) were significantly
enhanced by hypoxia for 1 hour, but were not changed by
hypoxia for 12 hours. In addition, in immunoblots of whole-
cell lysates, protein levels of MFG-E8 expression in 10T1/2
cells were also increased by hypoxic conditions (Figure 1d).
These results suggest that ischemia-induced hypoxia in the
skin may enhance the expression of MFG-E8 in pericytes/
vascular SMCs and ECs in I/R sites.
rMFG-E8 protected ulcer formation after cutaneous I/R
To assess the effect of rMFG-E8 on cutaneous pressure ulcers
after I/R in vivo, we compared the wound area after I/R injury
in normal C57BL/6 mice treated with subcutaneous injection
of rMFG-E8 or phosphate-buffered saline as a control. We
used a simple, reproducible, and noninvasive experimental
mouse model to evaluate the pathogenesis of cutaneous
pressure ulcers by I/R in vivo (Stadler et al., 2004; Saito
et al., 2008). Administration of rMFG-E8 significantly inhibited
the formation of cutaneous pressure ulcers after I/R (Figure 2a
and b). At 3 days after reperfusion, wound areas in rMFG-E8-
treated mice were 60% of the wound areas in control mice.
Wound areas in rMFG-E8-treated mice were significantly
smaller than those in control mice from 1 to 8 days after
reperfusion. The wound closure time in control mice was
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significantly longer than that in rMFG-E8-treated mice. These
results demonstrate that rMFG-E8 partially protected the
formation of cutaneous pressure ulcers after I/R.
To further examine the protective effect of MFG-E8 on I/R
injury, we compared the wound area after I/R in MFG-E8 WT
and KO mice. Wound areas in the MFG-E8 KO mice tended
to be larger than those in WT mice. At 2 days after reperfusion,
wound areas in MFG-E8 KO mice were significantly larger
than those in WT mice (Figure 2c). This result may partially
support the results that rMFG-E8 injection protected against
cutaneous I/R injury.
rMFG-E8 suppressed infiltrating macrophages, especially M1
macrophages, into cutaneous I/R area
Infiltrating neutrophils and macrophages participate in I/R
injury by regulating inflammation and angiogenesis. There-
fore, we next analyzed the effect of rMFG-E8 on infiltrating
neutrophils and macrophages after cutaneous I/R injury. At 1
day after reperfusion, the prominent edema in the dermis and
the infiltration of inflammatory cells in the hypodermis were
histologically observed (data not shown). The numbers of
infiltrating MPOþ neutrophils in control mice were compar-
able to those in rMFG-E8-treated mice at 1 day after
Ischemia
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Figure 1. MFG-E8 mRNA expression during ischemia–reperfusion (I/R) injury and hypoxia treatment. (a) Quantification of MFG-E8 mRNA levels in the I/R site
from the beginning of ishemia to 72 hours after reperfusion by quantitative reverse transcriptase–PCR (RT–PCR). The end of ischemia was assigned 0. Data are
relative to mRNA level in 0 h. Values were determined in n¼3 mice. (b) Expression and distribution of MFG-E8 in the skin during I/R injury ( 12 hours: before
ischemia, 0 hour: just after reperfusion, 72 hours: 72 hours after reperfusion). Scale bar¼20mm. Data are representative of n¼3 independent experiments. (c)
Quantification of MFG-E8 mRNA levels in pericytes, endothelial cells, and fibroblasts by quantitative RT–PCR. Cells were treated with hypoxia for the indicated
times. The amount of MFG-E8 expression in nontreated cells was assigned a value of 1. Values were determined in three independent experiments. **Po0.01,
*Po0.05 relative to nontreated cells. (d) MFG-E8 protein levels in 10T1/2 cells by immunoblotting. 10T1/2 cells were treated with hypoxia or normoxia conditions
for 24 hours. Data are representative of n¼3 independent experiments.
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reperfusion (Figure 3a). However, the numbers of CD68þ
macrophages in rMFG-E8-treated mice were significantly
decreased (Figure 3b), suggesting that rMFG-E8 might regulate
accumulation or functions of macrophages.
Local microenvironment influences the phagocytic and
secretory behavior of macrophages to promote the development
of either classically activated macrophages (M1 macrophages)
or alternatively activated macrophages (M2 macrophages;
Lawrence and Natoli, 2011; Ferrante and Leibovich, 2011).
M1 macrophages are observed in initial tissue damage
responses, and they induce inflammation by the secretion of
proinflammatory mediators, including MCP-1, NO, IL-1, IL-6,
IL-12, and TNF-a (Mosser, 2003; Lawrence and Natoli, 2011).
M2 macrophages have an essential role in early and middle
stages of wound healing, and they induce the resolution of
inflammation and promote tissue repair. Therefore, we next
examined the numbers of M1/M2 macrophages in I/R areas. The
number of total CD68þ macrophages and CD68þ , iNOSþ M1
macrophages in I/R areas in rMFG-E8-treated mice
were significantly reduced compared with those in control
mice (Figure 3c). In addition, the numbers of CD68þ , argi-
nase-1þ M2 macrophages in the I/R area in rMFG-E8-treated
mice were significantly reduced (Figure 3d). mRNA levels of
iNOS and arginase-1 in I/R areas in rMFG-E8-treated mice were
also significantly reduced (Figure 3e). Although M1 macro-
phage/total macrophage ratios in the wound area in rMFG-E8-
treated mice were reduced, M2 macrophage/total macrophage
ratios in the wound area in rMFG-E8-treated mice were not
different from those in control mice, suggesting that rMFG-E8
might suppress the number of total macrophages, especially M1
macrophages, which infiltrated into the wounded area.
rMFG-E8 suppressed apoptotic cells after cutaneous I/R
I/R-induced reactive oxygen species causes apoptosis and
subsequent exaggerated inflammatory responses induced by
secondary necrosis (Miksa et al., 2009; Aziz et al., 2011). To
examine the influence of MFG-E8 on the number of apoptotic
cells in I/R areas, TUNEL staining of skin sections was
performed. At 1 day after reperfusion, the number of
apoptotic cells in I/R areas in rMFG-E8-treated mice were
decreased compared with those in control mice (Figure 4).
These results suggest that rMFG-E8 might suppress the forma-
tion and/or accumulation of apoptotic cells induced by
cutaneous I/R injury.
rMFG-E8 suppressed the production of proinflammatory
cytokines and chemokines after cutaneous I/R
Next we investigated the effect of MFG-E8 on the mRNA
levels of proinflammatory cytokines and chemokines, includ-
ing MCP-1, IL-1b, TNF-a, and IL-6, in the I/R area by real-time
PCR. Treatment with rMFG-E8 significantly suppressed mRNA
levels of proinflammatory cytokines and chemokines
(Figure 5a–d). These results suggest that rMFG-E8 might
suppress the inflammation of skin after I/R.
Next we examined the production of intracellular inflam-
matory cytokines and chemokines in infiltrating macrophages
in the I/R sites using fluorescence-activated cell sorting
analysis, because macrophages, rather than neutrophils, are
major sources of proinflammatory cytokines and chemokines,
including IL-6, TNF-a, and MCP-1. Similar to the results of
histological analyses depicted in Figure 3, the total number of
infiltrating CD68þ macrophages in I/R sites was inhibited by
rMFG-E8 treatment (Figure 5e). The ratios of MCP-1þ macro-
phages/total macrophages, TNF-aþ macrophages/total macro-
phages, and IL-6þ macrophages/total macrophages in I/R sites
were also inhibited by rMFG-E8 treatment (Figure 5f–h). These
results suggest that rMFG-E8 might inhibit the recruitment of
macrophages, as well as the production of proinflammatory
cytokines and chemokines, in macrophages.
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Figure 2. rMFG-E8 protected pressure ulcer formation after cutaneous
ischemia–reperfusion (I/R). (a) The size of the wound area after I/R injury in
normal C57BL/6 mice treated with subcutaneous injection of rMFG-E8 or
phosphate-buffered saline as a control. The size of the ulcer in control mice at
3 days after reperfusion was assigned a value of 100% (Control: n¼ 10, rMFG-
E8: n¼ 10, for each time point and group). **Po0.01, *Po0.05. (b)
Photographs of the wound after cutaneous I/R in control or rMFG-E8 mice at 0,
2, 4, 6, 8, and 12 days after reperfusion. (c) The size of the wound area after I/R
injury in MFG-E8 wild-type (WT) and KO (knockout) mice. The size of the
ulcer in WT mice at 3 days after reperfusion was assigned a value of 100%.
n¼ 5 mice per genotype. *Po0.05.
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rMFG-E8 promoted angiogenesis in the I/R area after cutaneous
I/R
We previously determined that blood vessel formation was
inhibited in cutaneous wound area in MFG-E8 KO mice,
suggesting that MFG-E8 might regulate angiogenesis in cuta-
neous wound healing. Therefore, we investigated the effect of
rMFG-E8 on vascularity in the I/R area. At 6 days after
reperfusion, the numbers of CD31þ ECs and NG2þ pericytes
in the I/R areas were significantly increased compared with
those in control mice (Figure 6a). The numbers of aSMAþ ( a-
smooth muscle actin) pericytes/vascular SMCs in I/R areas in
rMFG-E8-treated mice tended to be more than those in control
mice (Figure 6b). These results suggest that rMFG-E8 might
enhance angiogenesis in I/R injury.
The effects of rMFG-E8 on IFA-induced skin inflammation
To examine whether the effects of rMFG-E8 are specific to I/R
injury or globally relate to skin inflammation, we next
analyzed the effect of MFG-E8 on the skin inflammation
induced by incomplete Freund’s adjuvant (IFA). It has been
known that IFA injection into the skin induced skin inflam-
matory response, such as inflammatory cells infiltration and
80
Neutrophil
(MPO+)
Macrophage
(CD68+)
**
**
**
**
***
*
*
60
60
50
40
30
20
10
0
40
20
0
Ctl
Co
nt
ro
l
rMFG-E8
Total macrophage
(CD68+)
6
5
4
3
2
1
0
5
4
3
2
1
0
4 1.2
1
0.8
0.6
0.4
0.2
0
1.2
1
0.8
0.6
0.4
0.2
0
1.2
1
0.8
0.6
0.4
0.2
0
0
2
4
6
8
10
12 1.2
1
0.8
0.6
0.4
0.2
0
3
2
1
0
Ctl rMFG-E8
iNOS Argnase-1
M1 macrophage /
total macrophage
M2 macrophage /
total macrophage
Total macrophage
(CD68+)
M2 macrophage
(CD68+, Arg-1+)
Ctl rMFG-E8 Ctl rMFG-E8 Ctl rMFG-E8 Ctl rMFG-E8 Ctl rMFG-E8
Ctl rMFG-E8Ctl rMFG-E8
Po
si
tiv
e
 a
re
a
 (%
)
iN
O
S 
ex
pr
es
sio
n
(iN
OS
/18
S)
Ar
gi
na
se
-1
 e
xp
re
ss
io
n
(ar
gin
as
e-1
1/1
8S
)
Po
si
tiv
e
 a
re
a
 (%
)
Po
si
tiv
e
 a
re
a
 (%
)
Po
si
tiv
e
 a
re
a
 (%
)
R
el
at
ive
 p
os
itiv
e
 a
re
a
R
el
at
ive
 p
os
itiv
e
 a
re
a
M1 macrophage
(CD68+, iNOS+)
CD68 CD68 Arg-1iNOS Merge Merge
Ctl rMFG-E8
rM
FG
-E
8
Co
nt
ro
l
rM
FG
-E
8
Co
nt
ro
l
rM
FG
-E
8
Co
nt
ro
l
rM
FG
-E
8
N
um
be
rs
 p
er
 h
.p
.
f.
N
um
be
rs
 p
er
 h
.p
.
f.
Figure 3. rMFG-E8 suppressed infiltrating macrophages, especially M1 macrophages, into the cutaneous ischemia–reperfusion (I/R) area. (a) The number of
infiltrating neutrophils in the I/R site at 1 day after reperfusion was determined by counting myeloperoxidase-positive cells. Values were determined in six random
microscopic fields in n¼ 3 mice per groups. Scale bar¼ 20mm. (b) The number of infiltrating macrophages in the I/R site at 1 day after reperfusion was determined
by counting CD68-positive cells. Values were determined in six random microscopic fields in n¼ 3 mice per group. **Po0.01. Scale bar¼20mm. (c, d)
Infiltration of CD68þ and induced nitric oxide synthase (iNOS)þ M1 macrophages (c) or CD68þ and arginase-1þ M2 macrophage (d) in the I/R area 1 day after
reperfusion. Quantification of the CD68þ , iNOSþ , and arginase-1þ areas in six random microscopic fields in n¼3 mice per group was performed using the
Image J software. The ratio of M1 or M2 macrophages (M1 or M2 macrophages/Total macrophages) in control mice was assigned a value of 1. **Po0.01,
*Po0.05. Scale bar¼ 20mm. (e) Quantification of iNOS and arginase-1 mRNA levels in I/R area at 1 day after reperfusion. n¼ 3 mice per group. *Po0.05.
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proinflammatory cytokines production (Vitoriano-Souza et al.,
2012). IFA-injected sites were treated with subcutaneous
injection of rMFG-E8 or phosphate-buffered saline as a
control. The appearance of skin at 1 day after IFA injection
did not differ between the two groups (Supplementary Figure
S1a online). rMFG-E8 treatment did not affect the number of
neutrophils, total macrophages, and M1 macrophages in the
IFA-injected site at 1 day after IFA injection (Supplementary
Figure S1b,c online). No significant difference in the number
of apoptotic cells was observed between the two groups
(Supplementary Figure S1e online). mRNA levels of iNOS,
arginase-1, MCP-1, IL-1b, TNF-a, and IL-6 in IFA-injected skin
in rMFG-E8-treated mice were also comparable to those in
control mice at 1 day after IFA injection (Supplementary
Figure S1d and S2 online). These results indicate that rMFG-
E8 did not modify IFA-induced skin inflammation.
DISCUSSION
This is a study to investigate the role of MFG-E8 in cutaneous
I/R injury. Using murine model (Stadler et al., 2004), we
determined that MFG-E8 expression was significantly
increased in the skin during ischemia, suggesting that MFG-
E8 expression might be enhanced by hypoxic conditions.
Immunofluorescence staining of MFG-E8 revealed that MFG-
E8 expression levels around ECs and pericytes/vascular SMCs
just after reperfusion (0 hour) were enhanced compared with
those before ischemia (12 hours) and at 72 hours after
reperfusion (72 hours), suggesting that ECs and pericytes/
vascular SMCs might be primary sources of MFG-E8 during
ischemia. In addition, we confirmed that mRNA and/or
protein levels of MFG-E8 in pericytes and ECs were
significantly enhanced by hypoxia in a time-dependent
manner. These findings suggest that hypoxia in ischemic
areas might be associated with the enhancement of MFG-E8
expression in pericytes/vascular SMCs and ECs. Previous
studies have reported that MFG-E8 mRNA and protein
expression in organs, including the kidney, liver, and gut,
were significantly decreased by I/R (Matsuda et al., 2011; Wu
et al., 2012; Deroide et al., 2013; Matsuda et al., 2013).
Consistent with these previous results, MFG-E8 expression in
cutaneous I/R areas was decreased by 0.5-fold at 72 hours
after reperfusion. The pathogenesis of the suppression of MFG-
E8 expression after I/R is currently unknown; however, we
suggest that I/R might cause severe damage of tissue, including
pericytes/vascular SMCs and ECs, and this I/R-induced
damage to the source of MFG-E8 may account for the
suppression of MFG-E8 expression after I/R. Kasuya
et al.(2014) reported that blood vessels in the I/R areas were
reduced compared with those in marginal zones after
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Figure 5. rMFG-E8 suppressed the production of proinflammatory cytokines after cutaneous ischemia–reperfusion (I/R). Quantification of mRNA levels of
monocyte chemotactic protein-1 (MCP-1) (a), IL-1b (b), tumor necrosis factor a (TNF-a) (c), and IL-6 (d) in the I/R area at 1 day after reperfusion by quantitative
reverse transcriptase–PCR (RT–PCR). mRNA levels in control mice were assigned values of 1. (e–h) Flow cytometry analyses of the production of intracellular
inflammatory cytokines and chemokines in infiltrated macrophages in the I/R site. (e) The relative number of infiltrated CD68þ macrophages in the I/R site. Total
number of macrophages in control mice was assigned a value of 1. (f) The relative ratio of MCP-1þ macrophages/total macrophages, (g) TNF-aþ macrophages/
total macrophages, and (h) IL-6þ macrophages/total macrophages in the I/R site. The ratio of MCP-1þ , TNF-aþ , or IL-6þ macrophages/total macrophages in
control mice was assigned a value of 1. n¼ 3 mice per group. **Po0.01, *Po0.05.
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reperfusion, suggesting that I/R-induced reactive oxygen
species might damage the blood vessels (Kasuya et al., 2014).
We determined that the injection of rMFG-E8 significantly
inhibited the formation of ulcers after I/R; however, the
differences of the formation of ulcers after I/R between
MFG-E8 WT and KO mice were not strikingly different.
The reason why the KO mice have not had a more
marked response is unknown. However, we suggest that the
immediate suppression of MFG-E8 expression in the I/R site
after I/R in WT mice may lead to no remarkable difference of
MFG-E8 expression in the I/R site after I/R between WT and
KO mice.
We identified rMFG-E8-mediated protective mechanisms of
cutaneous I/R injury, including (i) suppression of macrophages,
especially M1 macrophages, infiltrating into the I/R area; (ii)
suppression of apoptotic cell accumulation; (iii) suppression of
proinflammatory cytokine synthesis; and (iv) enhancement of
angiogenesis. We recently demonstrated that MFG-E8 regu-
lates angiogenesis and wound healing in a cutaneous wound
healing mice model (Uchiyama et al., 2014). In the present
study using a murine I/R model, we additionally determined
that MFG-E8 regulates the functions of M1 macrophages,
including the secretion of proinflammatory cytokines.
M1 macrophages infiltrate in the early phase of response to
tissue damage, and they are involved in cutaneous injury and
inflammation by secreting proinflammatory mediators, includ-
ing MCP-1, NO, IL-1, IL-6, IL-12, and TNF-a (Mosser, 2003;
Saito et al., 2008; Lawrence and Natoli, 2011). Therefore, our
results indicate that MFG-E8 suppresses the M1 macrophage
infiltration, through which cutaneous inflammation induced
by proinflammatory mediators from M1 macrophages is
restrained. With respect to M1 macrophages and MFG-E8, it
has been reported that coculture of macrophages with
apoptotic prostate cancer cells increased efferocytosis,
elevated MFG-E8 expression levels, and induced macro-
phage polarization into the M2 phenotype (Soki et al.,
2014). They also demonstrated that MFG-E8 enhanced the
phosphorylation of STAT3, and inhibited SOCS3, a negative
regulator of STAT3, therefore keeping STAT3 signaling
activated and promoting M2 polarization. This study
suggests that rMFG-E8 might induce M2 macrophage
polarization in the I/R area, resulting in the suppression of
M1 macrophage ratios. However, M2 macrophage ratios were
not increased by rMFG-E8 treatment in our experiments.
Therefore, further studies are required to clarify the effect of
MFG-E8 on M1/M2 macrophages.
It has been well recognized that MFG-E8 acts as a bridging
protein between phosphatidylserine on apoptotic cells and
integrin avb3/5 on phagocytes, thereby enhancing phagocytosis
and clearance of apoptotic cells (Hanayama et al., 2002; Asano
et al., 2004). In an experimental sepsis model using cecal
ligation and puncture, MFG-E8-containing exosome admini-
stration attenuated the acute systemic inflammatory response in
sepsis by enhancing apoptotic cell clearance (Miksa et al.,
2009). We showed that treatment with rMFG-E8 decreased I/R-
induced apoptotic cell accumulation. These findings suggest
that the decreased levels of MFG-E8 after cutaneous I/R may be
associated with impaired phagocytosis, leading to the
accumulation of apoptotic cells in the I/R area, and that the
administration of rMFG-E8 may enhance phagocytosis of
apoptotic cells, leading to the suppression of apoptosis and
necrosis in the I/R area and protection from pressure ulcers.
We assessed vascularity in I/R areas, and found that the
numbers of ECs and pericytes in the I/R areas were signifi-
cantly more than those in control mice. We assume that the
protective effect of rMFG-E8 on cutaneous I/R injury might be
associated with both suppression of inflammation and promo-
tion of angiogenesis.
Finally, we demonstraed that rMFG-E8 did not affect IFA-
induced skin inflammation, suggesting that the inhibition of
skin inflammation by rMFG-E8 treatment may be relatively
restricted in cutaneous I/R injury. However, further investiga-
tion may be warranted in additional skin inflammation models.
Taken together, we conclude that MFG-E8 suppresses the
formation of pressure ulcers induced by cutaneous I/R injury
by regulating inflammation and angiogenesis. Exogenous
MFG-E8 administration has possible therapeutic potential for
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Figure 6. rMFG-E8 promoted angiogenesis in the ischemia–reperfusion (I/R)
area after cutaneous I/R. (a) The amount of CD31þ ECs and NG2þ pericytes
in the cutaneous I/R area at 6 days after reperfusion. (b) The amount of a-
smooth muscle actin (aSMAþ ) myofibroblast or pericytes in the cutaneous I/R
area at 6 days after reperfusion. Quantification of the CD31þ , NG2þ , and
aSMAþ areas in 6 random microscopic fields in n¼ 3 mice per group was
performed using the Image J software. Positive area in control mice was
assigned a value of 1. **Po0.01, *Po0.05.
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cutaneous I/R injuries, including decubitus ulcers and Ray-
naud’s phenomenon–induced digital ulcers.
MATERIALS AND METHODS
The detailed protocols and statistical analysis are described in
Supplementary Materials and Methods online.
Mice
C57BL/6 mice were purchased from the SLC (Shizuoka, Japan). 8- to
12-week-old mice were used for all experiments. MFG-E8 KO
C57BL/6 mice were generated as previously described (Neutzner
et al., 2007; Motegi et al., 2011a). All experiments were approved by
the Ethical Committee for Animal Experiments of the Gunma
University Graduate School of Medicine and carried out in
accordance with the approved guidelines.
I/R cycles and analysis
The I/R model that has been previously reported was used (Peirce et al.,
2000; Stadler et al., 2004; Saito et al., 2008). The dorsal skin was gently
pulled up and trapped between two round ferrite magnetic plates that
had a 12-mm diameter (113 mm2) and that were 5-mm thick (NeoMag
Co, Ichikawa, Japan ) for 12 hours, and then plates were removed. All of
the mice developed two round ulcers separated by a bridge of normal
skin. For analysis, each wound site was digitally photographed after
wounding, and the wound areas were measured on photographs using
Image J (version 1.48, NIH, Bethesda, MD). To assess the effects of
rMFG-E8 on wound healing after cutaneous I/R injury, 400ng of rMFG-
E8 (R&D systems, Minneapolis, MN) per 50ml of phosphate-buffered
saline or 50ml of phosphate-buffered saline as a control were injected
into the dermis in the I/R site at the beginning of reperfusion.
Real-time RT–PCR
To analyze the mRNA levels of expression in the I/R site by real-time
RT–PCR, the whole-skin samples in the I/R site were used. Real-time
RT–PCR was performed as described in Supplementary Materials and
Methods online.
Statistics
P-values were calculated using the Student’s t-test (two-sided) or by
analysis of one-way analysis of variance followed by Bonferroni’s post
test, as appropriate. Error bars represent s.e.m., and numbers of
experiments (n) are as indicated.
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